Randomized Phase II Trial of Re-Irradiation and Concurrent Bevacizumab versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma (NRG Oncology/RTOG 1205): Initial Outcomes and RT Plan Quality Report

C Tsien; S Pugh; A.P Dicker; J.J Raizer; M.M Matuszak; E Lallana; J Huang; O Algan; N Taylor; L Portelance; J Villano; J Hamm; K.S Oh; A.N Ali; M.M Kim; S Lindhorst; M.P Mehta

doi:10.1016/j.ijrobp.2019.06.539

Back

Journal article

Randomized Phase II Trial of Re-Irradiation and Concurrent Bevacizumab versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma (NRG Oncology/RTOG 1205): Initial Outcomes and RT Plan Quality Report

C Tsien, S Pugh, A.P Dicker, J.J Raizer, M.M Matuszak, E Lallana, J Huang, O Algan, N Taylor, L Portelance, …

International journal of radiation oncology, biology, physics, Vol.105(1), pp.S78-S78

2019-09-01

DOI: https://doi.org/10.1016/j.ijrobp.2019.06.539

Metrics

85 Record Views

32 Times Cited - Web of Science

See more details

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.113 Brain Imaging; 1.113.453 Glioblastoma
Web Of Science research areas: Oncology; Radiology, Nuclear Medicine & Medical Imaging
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Randomized Phase II Trial of Re-Irradiation and Concurrent Bevacizumab versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma (NRG Oncology/RTOG 1205): Initial Outcomes and RT Plan Quality Report
Creators: C Tsien - Washington University School of Medicine, Department of Radiation Oncology, St. Louis, MO
S Pugh - NRG Oncology Statistics and Data Management Center, Philadelphia, PA
A.P Dicker - Thomas Jefferson University, Philadelphia, PA
J.J Raizer - Department of Neurology, Division of Neuro-Oncology, Northwestern University Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
M.M Matuszak - Department of Radiation Oncology, University of Michigan, Ann Arbor, MI
E Lallana - Kaiser Permanente Sacramento Medical Center, Sacramento, CA
J Huang - Washington University School of Medicine, Department of Radiation Oncology, St. Louis, MO
O Algan - University of Oklahoma Health Sciences Center, Oklahoma City, OK
N Taylor - Thomas Jefferson University Hospital-St. Luke's University-Bethlehem, Bethlehem, PA
L Portelance - University of Miami, Miami, FL
J Villano - University of Kentucky/Markey Cancer Center, Lexington, KY
J Hamm - Norton Hospital Pavilion and Medical Campus, Shelbyville, KY
K.S Oh - Massachusetts General Hospital, Boston, MA
A.N Ali - Department of Radiation Oncology at Emory University, Atlanta, GA
M.M Kim - University of Michigan, Ann Arbor, MI
S Lindhorst - Medical University of South Carolina, Charleston, SC
M.P Mehta - Miami Cancer Institute, Baptist Health South Florida, Miami, FL
Publication Details: International journal of radiation oncology, biology, physics, Vol.105(1), pp.S78-S78
Publisher: Elsevier Inc
Academic Unit: Miller School of Medicine; UMMG Dept of Radiation Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031600207902976